DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

454.50 6.13 (1.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $454.50 1.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $449.48
Previous Close $448.38
Daily Range $448.04 - $460.12
52-Week Range $269.50 - $495.50
Market Cap $46.6B
P/E Ratio 146.05
Dividend (Yield) $0.00 (0.0%)
Volume 856,036
Average Daily Volume 918,298
Current FY EPS $7.79

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

Ohr Pharmaceutical: Undervalued Biotech Set To Possibly Challenge Regeneron's Eylea Drug

Regeneron's Eylea Gets FDA Approval for Label Expansion - Analyst Blog

Stock Market News for March 26, 2015 - Market News

Jim Cramer's 'Mad Money' Recap: This Market Has Gotten Too Hot

Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blo

Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blog

Dow drops 200 points as economy shows cracks

How Big Will The Biotech Bubble Get?

High Alert for Signs of Biotech Collapse Makes for Nervous Investors

Biotech Bubble? Not Really, With One Exception

See More REGN News...

REGN's Top Competitors

REGN $454.50 (1.37%)
Current stock: REGN
AMGN $162.59 (1.27%)
Current stock: AMGN
GILD $101.00 (-0.07%)
Current stock: GILD
BIIB $429.87 (0.22%)
Current stock: BIIB